Recently Dr Carmen Martínez Fernández was incorporated as a postdoc into the Dr Griñan-Ferré group on Neuroepigenetics and Drug Discovery. Dr Martínez-Fernández will be in charge of Behavioural phenotypes evaluation (locomotion, mechano- and chemosensation) and Gene editing by CRISPR/Cas by using as experimental model C. elegans. She will participate in several projects lead By Dr Griñán-Ferré related with drug development.
11F – International Day of Women and Girls in Science
Every February 11th, we celebrate the International Day of Women and Girls in Science, a day dedicated to recognizing the…
February 11, 2025
